Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years.
Breast cancer research : BCR 2019 May 21 (1): 58.
Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor
Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations.
Breast cancer research and treatment 2008 Nov 112 (1): 159-64.
Kleibl Zdenek, Havranek Ondrej, Novotny Jan, Kleiblova Petra, Soucek Pavel, Pohlreich Pe